An Overview of the Development and Preclinical Evaluation of Antibody–Drug Conjugates for Non-Oncological Applications

Typically, antibody–drug conjugates (ADCs) are made up of a humanized antibody and a small-molecule medication connected by a chemical linker. ADCs’ ability to deliver cytotoxic agents to the specific site with reduced side effects showed promising results in oncology. To date, fourteen ADCs have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Lal Bahadur, Bule, Prajakta, Khan, Wahid, Chella, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385119/
https://www.ncbi.nlm.nih.gov/pubmed/37513995
http://dx.doi.org/10.3390/pharmaceutics15071807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385119/
https://www.ncbi.nlm.nih.gov/pubmed/37513995
http://dx.doi.org/10.3390/pharmaceutics15071807

Ejemplares similares